ReviewCureus2024
Wearable Technology and Chronic Illness: Balancing Justice and Care Ethics.
Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The role of wearable technologies in supporting physical and psychosocial health outcomes among breast cancer patients: a systematic review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Pooled it
- Wearable Technologies for Health Promotion and Disease Prevention in Older Adults: Systematic Scoping Review and Evidence Map.Journal of medical Internet research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The management of chronic diseases has been revolutionized by the advent of wearable health technology. These devices provide personalized and real-time health data to patients. The problem that this technology is most frequently used to address is obesity and its consequences, heart disease, and certain cancers. Numerous studies have shown a correlation between being at a healthy weight and having a lower risk of developing these conditions. Yet, many smart health devices in the wearable technology sector are only, and most of the time, within the context of weight management or obesity. The major research question directing this exploration is as follows: How can the use of wearable technologies be effective in improving the management and quality of life of people with chronic health problems? The question carries with it another that is almost as important: Does the use of these devices move us toward a more moral and just healthcare system, or does it unfairly advantage some groups of patients over others? This research will focus on three specific types of wearable devices, chosen as representative case studies. They are (1) the smartwatch, a more recent advancement in wearable technology that monitors the user's heart rate and physical activity; (2) the continuous glucose monitor (CGM), which presents real-time glucose levels for the user; and (3) the continuous positive airway pressure (CPAP) device, also called a respirator, worn during sleep by individuals diagnosed with sleep apnea. Each of these devices has the potential to not only revolutionize the management of chronic health conditions but also raise some important questions about the ethics of doing so.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.